NDC 51662-1587-2 - XYLOCAIN (LIDOCAINE HCl )
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1587
- Requested NDC
- 51662-1587-2
- Package NDCs from labels
- 51662-1587-1, 51662-1587-2, 51662-1587-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2025-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| XYLOCAIN (LIDOCAINE HCl ) - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1587-1 | XYLOCAIN (LIDOCAINE HCl ) | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 4 | |
| 51662-1587-2 | XYLOCAIN (LIDOCAINE HCl ) | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 4 | |
| 51662-1587-3 | XYLOCAIN (LIDOCAINE HCl ) | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1587 | XYLOCAIN (LIDOCAINE HCL ) (XYLOCAINE (LIDOCAINE HCL )) INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 4 | Current NDC, Legacy NDC, 3 package rows | 20250509_e1838a93-7f2a-14f1-e053-2a95a90a8d69.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2026-10-28 | Warnings | 451W47IQ8X |
| Articaine HCL and Epinephrine | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Aira LLC | 905cade1-9b37-486a-ac12-21f3262ab4e2 | 2026-10-27 | Warnings, Adverse reactions | 30Q7KI53AK |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | A-S Medication Solutions | 3b0282a6-9bfd-4052-b69c-2c68d488d009 | 2026-10-22 | Warnings, Adverse reactions | 1010033 |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-10-19 | Warnings, Adverse reactions | 1737757 1737343 1010900 1010033 1010671 1737562 1737566 1737568 |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | 60efd409-3555-4182-a68d-1cd7bc0d1bfc | 2026-10-19 | Warnings, Adverse reactions | 30Q7KI53AK |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Safco Dental Supply Co | 6721c3ab-c37f-4504-aebc-0103c56ed567 | 2026-10-08 | Warnings, Adverse reactions | 30Q7KI53AK |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 55a8372e-70d6-4b70-ac95-5226d0f5812a | 2026-10-07 | Warnings, Adverse reactions | 1737761 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 5b74b6f4-f26f-4243-8060-cd1777907984 | 2026-10-07 | Warnings, Adverse reactions | 1737566 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.